IMUGENE LIMITED — Capital/Financing Update 2014

Nov 11, 2014

==> picture [175 x 57] intentionally omitted <==

Imugene Limited ACN 009 179 551

12[th] November 2014

Suite 1, 1233 High Street Armadale VIC 3142

Imugene – additional placement details

Imugene Limited ACN 009 179 551 (ASX: IMU) ( Imugene ) today announced completion of the issue of 210 million fully paid ordinary shares with ‘sophisticated investors’ at $0.01 per share raising $2.10 million before costs of the issue. Subject to shareholder approval at Imugene’s 2014 AGM, a further 15 million shares will be issued to an associated entity of Imugene director, Otto Buttula, raising a further $0.15 million.

In accordance with Listing Rule 3.10.5A, Imugene advises as follows in relation to the placement:

• 1 The dilution to existing shareholders as a result of the placement is as follows:

  • (a) issue under Listing Rule 7.1 – 12.3%; and

  • (b) issue under Listing Rule 7.1A – 9.9%,

resulting in a total dilution of 22.2%.

• 2 Further details of the approximate percentage of the issued capital post the 7.1 and 7.1A placement (of 210,000,000 shares) held by the pre-placement security holders and new security holders are as follows:

Pre-placement security holders who did notparticipate in the placement	99.23%
Pre-placement security holders who didparticipate in the placement	0.77%
Participants in the placement who were notpreviously security holders	67.31%

• 3 Imugene issued shares to sophisticated and institutional investors as it was considered to be a more efficient mechanism for raising the Company’s immediate capital needs. The placement did not expose Imugene to the market volatility that may have been experienced over a more protracted capital raising process.

• 4

  • No underwriting agreements were in place for the placement.

• 5 The lead manager, Forrest Capital Pty Ltd, is entitled to a management fee of 2% and a selling fee of 4% of the gross proceeds raised under the placement.

IMUGENE LIMITED Telephone +61 3 9824 5254 Fax +61 3 9822 7735 Website www.imugene.com

==> picture [175 x 57] intentionally omitted <==

For further information contact:

Justyn Stedwell/Phillip Hains Joint Company Secretaries Imugene Limited

Telephone: +61 3 9824 5254 Facsimile: +61 3 9822 7735 Website: http://www.imugene.com

IMUGENE LIMITED Telephone +61 3 9824 5254 Fax +61 3 9822 7735 Website www.imugene.com

2